Stroke Thrombectomy and Aneurysm Registry
STAR
1 other identifier
observational
40,000
9 countries
63
Brief Summary
This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood vessels, abnormal formation of blood vessels, tearing of vein, and bleeding in the brain. This information is used to help predict outcomes that undergo an operation for treatment of the above-listed brain injuries. Additionally, the information is used to compare techniques and devices' effects on technical and clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2019
Longer than P75 for all trials
63 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 17, 2019
CompletedFirst Submitted
Initial submission to the registry
August 3, 2021
CompletedFirst Posted
Study publicly available on registry
August 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2055
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2055
December 24, 2025
December 1, 2025
35.3 years
August 3, 2021
December 18, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Post-procedure hemorrhage rate changes
Researchers examine changes in hemorrhage rates in post-stroke patients
90 days
Occlusion rates
Measure of how thrombectomy procedure success in relation to reduced occlusion
90 days
Complication rates
Measure of post-procedure complication rates in stroke/aneurysm patients
90 days
Retreatment rates
Measure of patient retreatment post-procedure
90 days
Study Arms (3)
Stroke
Thrombectomy
Aneurysm
Interventions
Participants are retrospectively and/or prospectively entered into registry based on disease indication and respective surgical procedure.
Eligibility Criteria
Any patients between 1 and 120 years of age, undergoing surgical intervention for central nervous system vascular lesions.
You may qualify if:
- Undergoing surgical intervention for central nervous system vascular lesion
- Between 1 and 120 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (63)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
Loma Linda University
Loma Linda, California, 92350, United States
Cottage Health Research Institute
Santa Barbara, California, 93105, United States
Nuvance Health
Danbury, Connecticut, 06810, United States
Yale University
New Haven, Connecticut, 06520, United States
University of Florida
Gainesville, Florida, 32611, United States
Mayo Clinic in Florida
Jacksonville, Florida, 32224, United States
University of Miami Health System
Miami, Florida, 33136, United States
University of South Florida
Tampa, Florida, 33620, United States
Piedmont Healthcare
Atlanta, Georgia, 30318, United States
Emory University
Atlanta, Georgia, 30322, United States
The Queens Health Center
Honolulu, Hawaii, 96813, United States
Rush University
Chicago, Illinois, 60612, United States
University of Chicago
Chicago, Illinois, 60637, United States
University of Illinois
Chicago, Illinois, 60637, United States
Endeavor Health
Evanston, Illinois, 60201, United States
Indiana University
Indianapolis, Indiana, 46202, United States
University of Iowa
Iowa City, Iowa, 52242, United States
University of Kansas Medical Center
Kansas City, Kansas, 66103, United States
University of Louisville
Louisville, Kentucky, 40292, United States
Tulane University
New Orleans, Louisiana, 70112, United States
Louisiana State University Health Shreveport
Shreveport, Louisiana, 71103, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
University of Michigan
Ann Arbor, Michigan, 48109, United States
University of Michigan Health-West
Wyoming, Michigan, 49519, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
Washington University in St. Louis
St Louis, Missouri, 63110, United States
Portsmouth Regional Hospital
Portsmouth, New Hampshire, 03801, United States
Rutgers University
New Brunswick, New Jersey, 08901, United States
Global Neurosciences Institute
Pennington, New Jersey, 08534, United States
Albany Medical Center
Albany, New York, 12208, United States
The Feinstein Institutes for Medical Research
Great Neck, New York, 11021, United States
Stony Brook University
Stony Brook, New York, 11794, United States
Montefiore Medical Center
The Bronx, New York, 10467, United States
University of North Carolina
Raleigh, North Carolina, 27607, United States
Wake Forest Baptist Health
Winston-Salem, North Carolina, 27157, United States
Mercy Health
Toledo, Ohio, 43608, United States
University of Oklahoma
Oklahoma City, Oklahoma, 73019, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Alleghany Hospital
Pittsburgh, Pennsylvania, 15212, United States
Geisinger Medical Group
Wilkes-Barre, Pennsylvania, 18702, United States
WellSpan York Hospital
York, Pennsylvania, 17403, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
University of Tennessee Health Science Center
Memphis, Tennessee, 38163, United States
The University of Texas Medical Branch at Galveston
Galveston, Texas, 77555, United States
Valley Baptist Medical Center
Harlingen, Texas, 78550, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
HCA Houston Healthcare Kingwood
Kingwood, Texas, 77339, United States
Texas Stroke Institute
Plano, Texas, 75075, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
University of Utah
Salt Lake City, Utah, 84112, United States
University of Virginia
Charlottesville, Virginia, 22904, United States
University of Washington
Seattle, Washington, 98195, United States
West Virginia University
Morgantown, West Virginia, 26506, United States
University of Saskatchewan
Saskatoon, Canada
Universitätsmedizin Göttingen
Göttingen, Germany
University Clinic for Neuroradiology
Magdeburg, Germany
Hyogo College of Medicine
Hyōgo, Japan
Centro Hospitalar Universitário de Lisboa Central
Lisbon, Portugal
Chonnam National University Hospital
Gwangju, South Korea
Hospital Universitario La Paz
Madrid, Spain
Universitätsspital Basel
Basel, Switzerland
Médica Uruguaya
Montevideo, Uruguay
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Meredith Robinson, MS
Medical University of South Carolina
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 90 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor-Faculty
Study Record Dates
First Submitted
August 3, 2021
First Posted
August 6, 2021
Study Start
September 17, 2019
Primary Completion (Estimated)
January 1, 2055
Study Completion (Estimated)
January 1, 2055
Last Updated
December 24, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share